Cargando…
Selectivity of Dietary Phenolics for Inhibition of Human Monoamine Oxidases A and B
Monoamine oxidases (MAOs) regulate local levels of neurotransmitters such as dopamine, norepinephrine, and serotonin and thus have been targeted by drugs for the treatment of certain CNS disorders. However, recent studies have shown that these enzymes are upregulated with age in nervous and cardiac...
Autores principales: | Zhang, Zhenxian, Hamada, Hiroki, Gerk, Phillip M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6364133/ https://www.ncbi.nlm.nih.gov/pubmed/30809547 http://dx.doi.org/10.1155/2019/8361858 |
Ejemplares similares
-
Natural Products Screening for the Identification of Selective Monoamine Oxidase-B Inhibitors
por: Zarmouh, Najla O., et al.
Publicado: (2016) -
Monoamine Oxidase B in Renal Cell Carcinoma
por: Hodorová, Ingrid, et al.
Publicado: (2018) -
Neuroprotective Function of Rasagiline and Selegiline, Inhibitors of Type B Monoamine Oxidase, and Role of Monoamine Oxidases in Synucleinopathies
por: Naoi, Makoto, et al.
Publicado: (2022) -
Methylxanthines Inhibit Primary Amine Oxidase and Monoamine Oxidase Activities of Human Adipose Tissue
por: Haj Ahmed, Wiem, et al.
Publicado: (2020) -
Monoamine Oxidase-A Occupancy by Moclobemide and Phenelzine: Implications for the Development of Monoamine Oxidase Inhibitors
por: Chiuccariello, Lina, et al.
Publicado: (2015)